# ServiceTitan, Inc. (TTAN) — Financial Analysis

**Exchange:** Nasdaq  
**Coverage as of:** 2026-Q2  
**Updated:** 2026-05-18  
**Tier:** Free primer (step 2 of 19)  
**Sibling pages:** /stocks/ttan/thesis · /memo/ttan

## Financial Snapshot

### Step 04 — Financial Statement Quality and Adjustments

**Ticker:** TTAN · **Step date:** 2026-04-23

---

#### Key Findings

- **The GAAP-to-adjusted bridge is dominated by SBC** [S1][S2]. FY26 GAAP operating loss $(169.2)M vs non-GAAP operating income of **$94.1M** — a **$263M swing**, of which $197M is stock-based compensation (20.5% of revenue). Other add-backs: ~$8M restructuring/impairments, ~$17M amortization of acquired intangibles, ~$4M acquisition-related items, employer payroll tax on SBC.
- **SBC is structurally high but is NORMALIZING downward.** FY25 SBC included **$59.1M of one-time IPO-triggered RSU vesting acceleration** + **~$53.6M of Co-Founder PSU grant-date expense recognized in G&A** (both identifiable via the 10-K SBC footnote) [S1]. Stripping these two non-recurring items, "steady-state" SBC would have been **~$51M** FY25 (6.6% of revenue) vs **$197M** reported — a ~$146M gap. FY26 SBC is $197M (~20.5% of revenue), still elevated but declining as a % of revenue from ~22% FY25 to ~18% in forecast trajectory. **SBC as a % of revenue is the single most important quality metric to monitor.**
- **One-time adjustments are mostly legitimate**, with two caveats:
  - IPO-triggered RSU vesting ($59.1M Q4 FY25) is genuinely non-recurring
  - Co-Founder PSU grant amortization will continue through the vesting life but is **heavily front-loaded** (graded-vesting expense recognition means most is taken in first 2-3 years post-grant; FY26 G&A included $53.6M of Co-Founder PSU SBC). FY27 and beyond will see this decay unless new Co-Founder grants are issued.
  - Lease impairment charges ($11M FY26, $39M FY25) are correctly excluded from run-rate as they reflect office-footprint rationalization, not operating cost.
- **Free Cash Flow quality is improving but not yet pristine.** FY26 FCF $85.6M (derived from OCF $110.1M − CapEx $24.6M) [S5]. The CFO flagged Q1 FY27 will go negative again due to annual corporate bonus payments paid in Q1 [S2] — so smoothed full-year FCF is the cleaner metric. **Adjusted FCF before SBC = heavily negative**, meaning FCF positive only because SBC is non-cash; true economic FCF after accounting for SBC dilution is roughly FCF − SBC = $85.6M − $197M = $(111)M. Bears will anchor here.
- **Balance-sheet-based adjustments (Step 04 perspective):** Goodwill $860M = 49% of total assets [S1]; intangibles $177M. Concentration of goodwill is material. Past acquisitions (FieldRoutes $84M, ServicePro, Pointman, Convex Labs, Conduit Tech) could generate impairments if acquired-vertical growth disappoints — no impairment taken to date.

##### **Adversarial Research Sweep (mandatory) — CLEAN**

Exhaustive search completed. **No short seller reports, fraud allegations, SEC investigations, class action lawsuits, or material controversies** were found targeting ServiceTitan as of April 2026.

Searches performed: `"TTAN short seller report"`, `"ServiceTitan short report"`, `"TTAN fraud allegations"`, `"ServiceTitan accounting fraud"`, `"TTAN short interest"`, `"ServiceTitan" "open letter" board`, `"TTAN class action lawsuit"`, `"TTAN SEC investigation"`, `"ServiceTitan" Muddy Waters OR Hindenburg OR Citron OR Spruce Point OR Kerrisdale OR Scorpion OR Iceberg OR Wolfpack OR Viceroy OR Quintessential OR Gotham OR "J Capital" OR Bonitas OR Fuzzy Panda OR Culper`.

Result: No named short-seller reports. No SEC enforcement action. No whistleblower complaint. No accounting restatement. No securities class action filed. No activist investor open letter. No CEO / CFO departure under pressure. No 8-K disclosing a regulatory inquiry.

**However, note the following non-controversial but adjacent items** (not fraud-related but worth documenting):
- **Short interest 10.05% of float** [S7] — elevated vs typical SaaS (usually 3-6%). Reflects bear *thesis* concentration (SBC burn, CAC doubt, MAX skepticism) but not a specific published short report.
- **2022 Series H ratchet** — Pre-IPO Series H round at ~$9.5B valuation included anti-dilution conversion-ratchet triggered at IPO pricing below reference price (Dec 2024 $71 IPO vs Series H $85-$90). This resulted in additional Class A issuance to Series H holders. **Not a governance controversy** — it's standard pre-IPO anti-dilution mechanics disclosed in the S-1 — but it explains some of the pre-IPO dilution to early-vintage investors [S6].
- **Co-Founder PSU "Musk-style" grant** ($263.6M combined grant-date fair value) — governance researchers have flagged as high-dollar, Tesla-template. No lawsuit filed as of April 2026. Structurally aligned with stock-price performance ($140-$440 hurdle ladder). Governance yellow flag but not a controversy [S6].

**Net of adversarial sweep:** ServiceTitan is one of the cleaner recent-IPO vertical SaaS stocks. The absence of any short report at 10% short interest is notable — bears are betting on valuation/SBC/growth compression, not on accounting integrity or business-model deception.

- **Net thesis impact of Step 04: POSITIVE** (quality improves, adjustments defensible, adversarial sweep clean). **The FY25 reported loss-per-share $(8.53) is noisy** but FY26 reported EPS $(1.73) is cleaner and sets an honest baseline. The next two years will see non-GAAP operating income step up materially as (a) IPO-related non-recurring SBC drops out of the comparison, (b) revenue scales against relatively fixed G&A, (c) lease impairment roll-off.

---

#### Implications for Thesis and Valuation

- **Primary earnings metric for Step 14 DCF: Non-GAAP operating income** — but with SBC added back as a cash-dilution cost in a separate "true economic FCF" line. Bulls and bears will anchor at different levels of the same bridge.
- **SBC dilution impact on per-share value:** $197M / ($64.59 × 95.3M shares) = **3.2% of market cap / year** in SBC-driven dilution. This is high for a ~25% grower at this scale but consistent with recent-IPO SaaS. Watch trajectory — management LT goal is for SBC as % of revenue to decline.
- **Reverse DCF sanity check:** Current EV of $5.78B implies the market is pricing roughly $450-500M of steady-state (~10 years out) non-GAAP operating income at a modest terminal multiple. FY26 non-GAAP op income of $94M × FY27 guide $130M midpoint → ~38% growth. If TTAN can sustain 20%+ non-GAAP op income growth for 5-7 years, the current valuation is reasonable to cheap. If SBC stays at 20%+ of revenue structurally, the valuation is stretched.
- **Goodwill concentration** (49% of assets) requires a Step 07 deep-dive on whether acquired verticals (pest, landscape, roofing tools) are generating returns — goodwill impairment risk exists but no current indicator.

---

#### Objective

Convert reported numbers into an analytically usable earnings base. Reconcile GAAP/IFRS to management-adjusted metrics. Test whether "one-time" charges are recurring. Complete exhaustive adversarial research sweep.

---

#### Narrative Analysis

##### The GAAP-to-non-GAAP bridge (FY2026)

Management presents non-GAAP gross profit, non-GAAP operating income, and non-GAAP net income, with the following add-backs [S1][S2]:

| GAAP Line | GAAP FY26 ($M) | Add-backs | Non-GAAP FY26 ($M) |
|-----------|---------------:|----------|-------------------:|
| Revenue | 961.0 | — | 961.0 |
| Cost of Revenue | (287.2) | +~21 (SBC in COGS + amort of acquired intangibles) | (266) |
| **Gross Profit** | **673.7** | | **~711 (74.0% GM)** |
| S&M | (290.9) | +~38 (SBC, impairment roll-off, employer payroll) | (253) |
| R&D | (302.6) | +~50 (SBC + impairment roll-off) | (252) |
| G&A | (249.5) | +~104 (SBC incl. Co-Founder PSU + acquisition-related + lease impairment roll-off + employer payroll) | (146) |
| **Op Income (Loss)** | **(169.2)** | **+263** | **+94.1** |
| **Non-GAAP Op Margin** | (17.6%) | | **9.8%** |

Source: [S1][S3].

The $263M bridge is dominated by:
- **Stock-based compensation: ~$197M** (across all OpEx lines)
- **Employer payroll tax on SBC: ~$15-20M**
- **Amortization of acquired intangibles: ~$38M** (from prior acquisitions: FieldRoutes, ServicePro, Pointman, Convex, Conduit)
- **Restructuring / lease impairment: ~$11M**
- **Acquisition-related items: ~$4M**

**None of these is suspicious.** They are standard SaaS non-GAAP adjustments. The debate isn't "are these real expenses?" — the debate is "how fast will SBC as a % of revenue shrink?"

##### SBC trajectory analysis

| FY | SBC ($M) | Revenue ($M) | SBC % of Revenue | Notes |
|----|---------:|-------------:|:----------------:|-------|
| FY2024 | 102.5 | 614.3 | 16.7% | Pre-IPO |
| FY2025 | 163.7 | 771.9 | 21.2% | Includes ~$59M one-time IPO trigger + ~$53.6M Co-Founder PSU G&A |
| FY2026 | 197.1 | 961.0 | 20.5% | Co-Founder PSU recognition continuing; normalized-run-rate still ~15-17% |
| FY2027e | ~210-220 | ~1,115 | ~18-19% | Co-Founder PSU expense recognition continues but decays; revenue scales |
| FY2028e | ~230-245 | ~1,330 | ~17-18% | Continued decay |

Source: [S1][S5], forward estimates derived.

**Key observation:** Reported SBC grew +20% YoY in FY26 while revenue grew +24.5% — SBC as % of revenue actually *declined* from 21.2% to 20.5%. This is the beginning of the normalization. If management continues to gate equity comp growth below revenue growth, the ratio steps down 100-200bps annually.

**Co-Founder PSU contribution to SBC decay:** The $263.6M total grant-date fair value amortizes via graded vesting across the hurdles (conditional on stock price achievement). Most graded-vesting expense is recognized in the first 2-4 years, tapering thereafter. Expect ~$40-60M/year of Co-Founder PSU SBC in FY27-FY29, declining.

##### "One-time" adjustment legitimacy test

| Adjustment | Claimed Non-Recurring? | Actually Non-Recurring? | Analyst Verdict |
|------------|:----------------------:|:-----------------------:|:---------------:|
| IPO-triggered RSU vesting ($59M Q4 FY25) | Yes | **Yes** — liquidity-event trigger | ✅ Valid |
| Co-Founder PSU grant ($263.6M total) | Management treats as recurring SBC | **Frontload-heavy, not strictly non-recurring** — but will decay | ⚠️ Partially legitimate |
| Lease impairments ($11M FY26, $39M FY25) | Yes (one-time office footprint rationalization) | **Yes** — real estate reshoring | ✅ Valid |
| Amortization of acquired intangibles (~$38M) | Yes (acquisition accounting) | **Depends** — will recur if M&A pace continues | ⚠️ Valid on deal-by-deal basis |
| Loss on extinguishment of debt ($1.5M FY26) | Yes | **Yes** — term loan payoff | ✅ Valid |
| Acquisition-related items (~$4M) | Yes (legal/advisory on Convex + Conduit) | **Yes for deal-specific costs** — will recur if M&A continues | ⚠️ Valid on deal-by-deal basis |
| Restructuring (minor in FY26) | Yes | **Yes** — but FY24/FY25 had larger workforce reductions | ✅ Valid |

**Verdict:** Management's non-GAAP methodology is conservative and defensible. Adjustments are not being used to paper over operating weakness.

##### Depreciation, amortization, and capitalized software

| Line ($M) | FY24 | FY25 | FY26 |
|-----------|:----:|:----:|:----:|
| Depreciation & amortization | 81.0 | 80.2 | 83.2 |
| Amortization of deferred contract costs | 9.4 | 11.5 | 14.9 |
| Capitalized internal-use software expense | 15.7 | 17.8 | 19.9 |
| PP&E capex | 28.4 | 3.8 | 4.7 |
| Total capex-like spend | 44.1 | 21.6 | 24.6 |

Source: [S5]. **Note:** PP&E capex dropped dramatically from $28M (FY24) to <$5M (FY25/FY26) — consistent with the office-footprint-rationalization (lease impairments). ServiceTitan is now a capital-light business: ~2.5% of revenue in total capex. This supports the margin-expansion thesis.

##### Contract asset / deferred contract cost build

| Line ($M) | Jan 2024 | Jan 2025 | Jan 2026 |
|-----------|:--------:|:--------:|:--------:|
| Deferred contract costs (current + non-current) | ~19 | 22.2 | 29.7 |
| Contract assets | — | 45.9 | 57.8 |
| Deferred revenue (current) | 11.2 | 16.8 | 18.7 |

Source: [S1][S5]. **Contract assets growing faster than deferred revenue** indicates revenue recognized ahead of billing — common in usage-based and multi-year subscription businesses. Not a red flag.

##### Key quality conclusions

**Strengths:**
- PwC-audited; critical audit matter is Platform revenue recognition (standard for vertical SaaS) [S4]
- No accounting restatements
- No material weakness in internal controls [S1]
- Conservative non-GAAP methodology
- FCF now positive and growing
- Clean cash flow statement with clearly identifiable cash generation

**Weaknesses / watch-items:**
- SBC at 20.5% of revenue — elevated
- Goodwill concentration (49% of assets)
- Co-Founder PSU amortization is "recurring" in the sense that it won't disappear quickly
- Credit loss provision up significantly ($9.3M FY26 vs $3.7M FY25 vs $2.6M FY24) [S5] — monitor customer credit quality as SMB base grows
- Deferred contract costs amortization period disclosure not crisply specified; implicit in customer life

---

#### Adversarial Research Sweep — Detailed

**Search queries executed (as required by Step 04 mandatory sweep):**

1. `"TTAN short seller report"` → **0 results**
2. `"ServiceTitan short report"` → **0 dedicated short reports found**
3. `"TTAN fraud allegations"` → **0 results**
4. `"ServiceTitan accounting fraud"` → **0 results**
5. `"TTAN short interest"` → confirms 10.05% of float but no specific report cited [S7]
6. `"ServiceTitan" "open letter" board` → **0 results**
7. `"TTAN class action lawsuit"` → **0 results** (only generic post-IPO law firm SEO-style "investigation" pages — none with substantive allegations)
8. `"TTAN SEC investigation" OR "TTAN regulatory investigation"` → **0 results**
9. `"ServiceTitan" Muddy Waters OR Hindenburg OR Citron OR Spruce Point OR Kerrisdale OR Scorpion OR Iceberg OR Wolfpack OR Viceroy OR Quintessential OR Gotham OR "J Capital" OR Bonitas OR Fuzzy Panda OR Culper` → **0 results** — none of the named short sellers have published on TTAN

**Completeness verification:** One final check — "Are there any short seller reports, regulatory investigations, class action lawsuits, whistleblower complaints, or significant controversies about ServiceTitan (TTAN) that have NOT been covered above?" → **No additional items surfaced.**

**Finding:** **No short seller reports, fraud allegations, or material controversies were found targeting ServiceTitan as of April 23, 2026.** This is a positive finding and substantially de-risks the thesis relative to IPOs that attract published short-seller research in their first 18 months (e.g., EquipmentShare's Neil Chheda federal lawsuit, Nayax's Israeli ICA consent decree — both documented in prior /full-research-gpt runs).

##### Non-controversial items worth noting separately

**(1) Elevated short interest (10.05% of float) [S7]**
Reflects *bear thesis concentration*, not a specific published short report. The bear consensus likely centers on:
- SBC burn / dilution
- MAX adoption skepticism
- Market expectations of 25%+ forward growth that would require continued beat-and-raise
- Governance (dual-class + Co-Founder PSU) as index-inclusion drag
- BuildOps competitive encroachment in commercial

Short interest of this magnitude is worth monitoring as a sentiment indicator but does not constitute an adversarial position backed by published research.

**(2) 2022 Series H ratchet conversion [S6]**
Pre-IPO anti-dilution mechanic. Series H investors (2022 round at ~$9.5B valuation) received additional Class A shares at IPO because pricing was below their reference. **Standard dilution-protection feature disclosed in the S-1** [S6]. Not a controversy — but explains some of the early-vintage-investor dilution and is worth understanding when modeling the pre-IPO cap table.

**(3) Co-Founder PSU grant [S6]**
$131.8M grant-date fair value to each co-founder (total $263.6M). Stock-price hurdle structure ($140/$240/$340/$440 6-month VWAP). No legal challenge filed. Governance yellow flag (three VC-linked directors approved on Comp Committee) but not a fraud or disclosure controversy.

**(4) Pre-IPO workforce reductions [S1]**
FY2024 and FY2025 saw restructuring charges. ~$18M in FY24 restructuring/impairment and ~$39M in FY25 lease impairments. Roughly 10% workforce reduction across 2022-2023 per media reports. Recovered by FY26 (3,414 Titans vs ~3,000 FY25 vs ~3,200 FY24). Normal SaaS operating discipline.

---

#### Evidence and Sources

##### SBC Detail (FY2026)

| Line | SBC Attribution ($M) | % of SBC |
|------|:--------------------:|:--------:|
| Cost of Revenue | ~20 | 10% |
| S&M | ~37 | 19% |
| R&D | ~55 | 28% |
| G&A | ~85 | 43% (incl. Co-Founder PSU) |
| Capitalized in software | ~4.6 | 2% |
| **Total SBC** | **$197.1M** | **100%** |

Source: [S1] (10-K disclosure).

##### FCF Quality (FY24→FY26)

| Line ($M) | FY24 | FY25 | FY26 |
|-----------|:----:|:----:|:----:|
| GAAP Net Loss | (195.1) | (239.1) | (159.9) |
| Add back: SBC | 102.5 | 163.7 | 197.1 |
| Add back: D&A | 81.0 | 80.2 | 83.2 |
| Add back: Lease impairments | 5.4 | 39.4 | 11.0 |
| Add back: Deferred contract amort | 9.4 | 11.5 | 14.9 |
| Net working-capital change | (68) | (22) | (51) |
| Operating Cash Flow (GAAP) | (39.7) | 37.1 | 110.1 |
| Less: CapEx | (44.1) | (21.6) | (24.6) |
| **Free Cash Flow** | **(83.8)** | **15.5** | **85.6** |
| FCF Margin % | -13.6% | 2.0% | 8.9% |
| **Adjusted FCF — after SBC (economic)** | **(186.3)** | **(148.2)** | **(111.5)** |

Source: [S5]. The "economic" FCF subtracts SBC entirely — this is the bear view.

##### Depreciation & Capex Analysis

| FY | D&A ($M) | PP&E + Cap Software ($M) | Capex / Revenue |
|----|:--------:|:------------------------:|:--------------:|
| FY24 | 81.0 | 44.1 | 7.2% |
| FY25 | 80.2 | 21.6 | 2.8% |
| FY26 | 83.2 | 24.6 | 2.6% |

Source: [S5]. Capital light at scale.

---

#### Assumption Register Updates

| ID | Step | Assumption | Type | Value | Unit | Basis | Sensitivity | Source |
|----|------|-----------|------|-------|------|-------|------------|--------|
| A38 | 04 | SBC as % of revenue (FY26) | Fact | 20.5% | % | 10-K | High — drives GAAP-to-economic bridge | S1 |
| A39 | 04 | Expected SBC decay | Judgment | -100-200bps/year through FY30 | pp/yr | Revenue scaling + Co-Founder PSU frontload | High | Derived from S1 |
| A40 | 04 | One-time IPO SBC charge (FY25 Q4) | Fact | $59.1M | $ | 10-K footnote | Low | S1 |
| A41 | 04 | Co-Founder PSU grant-date fair value | Fact | $263.6M combined | $ | DEF 14A / 10-K Item 11 | High — structural adjustment | S6 |
| A42 | 04 | Adversarial research sweep | Judgment | Clean — no short reports, investigations, or material controversies | — | Comprehensive Apr 2026 search | Low — reduces tail risk | Step 04 sweep |
| A43 | 04 | Goodwill concentration | Fact | 49% of total assets | % | Balance sheet | Medium — impairment risk if M&A underperforms | S1 |
| A44 | 04 | Capex intensity | Fact | ~2.5% of revenue | % | Cash flow stmt | Low — already reflected in FCF | S5 |
| A45 | 04 | True-economic FCF (FCF − SBC) | Estimate | $(111.5)M FY26 | $ | Derived | High — bear anchor | S5 |

---

#### Tables and Calculations

##### Non-GAAP Operating Income Trajectory

| FY | Revenue ($M) | GAAP Op Loss ($M) | Non-GAAP Op Inc ($M) | Non-GAAP Op Margin |
|----|-------------:|------------------:|---------------------:|:------------------:|
| FY2023 | 467.7 | (221.9) | ~(80) | -17% |
| FY2024 | 614.3 | (182.9) | ~(25) | -4% |
| FY2025 | 771.9 | (230.0) | 25.2 | 3.3% |
| FY2026 | 961.0 | (169.2) | 94.1 | 9.8% |
| FY2027e | 1,115 | ~(120) | 130 | 11.7% |
| LT target | — | breakeven | **~25%** | **~25%** |

Source: [S3][S5]. LT target from Pantheon 2025 [S12].

##### Critical Audit Matter (PwC): Platform Revenue Recognition

Per the 10-K, PwC identified Platform Revenue Recognition as the Critical Audit Matter due to the complexity of:
- Subscription (ratable recognition across 12-36 month contract terms)
- Usage-based (recognition at transaction, net of interchange)
- Contract modifications
- Standalone selling price allocation for bundled products

No material misstatements noted. Source: [S1].

---

#### Open Questions and Data Gaps

1. **Exact amortization schedule for Co-Founder PSU expense** — graded-vesting methodology is standard but year-by-year P&L impact isn't published.
2. **Credit loss provision trajectory** — up 150%+ YoY. At ~1% of revenue now. Not alarming but worth tracking.
3. **Detailed acquisition ROIC (Convex, Conduit, FieldRoutes, ServicePro, Pointman)** — deferred to Step 07 (Capital Allocation).
4. **Lease impairment residual** — most office footprint rationalization appears complete but another $11-15M possible in FY27 based on remaining ROU asset balance.
5. **Virtual Agents SBC allocation** — as Virtual Agents usage revenue scales, how is R&D SBC allocated across the stack? Not disclosed.

---

#### Next-Step Dependencies

**Step 05 (Quarterly Momentum)** will use non-GAAP operating income trajectory to track the margin-expansion story quarter-by-quarter.

**Step 07 (Capital Allocation)** will test Goodwill concentration via acquisition-by-acquisition ROIC analysis.

**Step 09 (Returns on Capital)** will apply SBC treatment to the ROIC calculation.

**Step 14 (Valuation)** will use A38 (SBC %), A39 (SBC decay), A44 (capex intensity), and A45 (true-economic FCF) as central inputs to scenario modeling.

---

#### Source Index

| Tag | Document | Section | Date | Notes |
|-----|----------|---------|------|-------|
| [S1] | 10-K FY2026 | Item 1, Item 7, Item 8 + footnotes | Mar 25, 2026 | Non-GAAP reconciliation, SBC detail, PSU grant amortization — `sec_filings/10K_FY2026_summary.md` |
| [S2] | Q4 FY2026 earnings call | Prepared remarks | Mar 12, 2026 | SBC, margin commentary, Co-Founder PSU recognition — `earnings/transcript_Q4_FY2026.md` |
| [S3] | Consolidated press releases | Non-GAAP margin progression | Mar 12, 2026 and prior | Quarterly Non-GAAP op income — `earnings/press_releases_Q1_FY2026_to_Q4_FY2026.md` |
| [S4] | 10-K FY2026 financial statements | PwC CAM, critical accounting policies | Mar 25, 2026 | Platform Revenue Recognition — `sec_filings/10K_FY2026_summary.md` |
| [S5] | XBRL financial summary | Cash flow statement | 2026-04-23 | D&A, capex, SBC, FCF derivation — `xbrl/xbrl_summary.md` |
| [S6] | Governance & compensation | Co-Founder PSU, Series H ratchet | 2026-04-23 | Structural adjustment context — `proxy/governance_and_compensation.md` |
| [S7] | StockAnalysis.com + insider transactions | Short interest, no insider purchases | 2026-04-23 | 10.05% short of float — `other/stockanalysis_summary.md`, `proxy/insider_transactions.md` |
| [S12] | Pantheon 2025 | LT margin targets | Sep 18, 2025 | 25% non-GAAP op margin target — `presentations/investor_presentation_2025_2026.md` |

## Deeper Financial Analysis

The fundamental tier ($1.00) adds 8 dimensions not included here:

- Revenue Breakdown — segment revenue, geographic mix, product-line margins
- Financial Trends — QoQ momentum, leading indicators, inflection points
- Balance Sheet — debt structure, dilution risk, working capital dynamics
- Capital Allocation — ROIC, buyback cadence, reinvestment efficiency
- Earnings Analysis — beats/misses, guidance vs actuals, transcript highlights
- Competitive Positioning — market share, pricing power, peer benchmarks
- Industry Context — TAM, sector tailwinds/headwinds, regulatory backdrop

**API endpoint:** GET /api/v1/research/TTAN/fundamental

## Navigation

- Overview: /stocks/ttan
- Financials (this page): /stocks/ttan/financials
- Thesis: /stocks/ttan/thesis
- Investment Memo: /memo/ttan
- Coverage universe: /stocks